6609 — Shanghai HeartCare Medical Technology Income Statement
0.000.00%
Last trade - 00:00- HK$1.97bn
- HK$1.11bn
- CNY408.29m
Annual income statement for Shanghai HeartCare Medical Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 90.1 | 183 | 232 | 278 | 408 |
| Cost of Revenue | |||||
| Gross Profit | 55 | 124 | 164 | 182 | 290 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 286 | 347 | 333 | 288 | 320 |
| Operating Profit | -196 | -164 | -101 | -10.2 | 88.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -198 | -201 | -103 | -12 | 86.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -198 | -200 | -94 | -13.6 | 83.3 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -194 | -200 | -94 | -13.6 | 83.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -194 | -200 | -94 | -13.6 | 83.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -4.86 | -5.24 | -2.49 | -0.361 | 2.28 |